| | | | | |
| €0,83427 | +2,26% | €169,90M | €438,48K | |
KLTR Kaltura, Inc. Common Stock | €1,1280 | +2,38% | €169,61M | €119,65K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €4,4070 | -0,98% | €169,56M | €120,33K | |
RDIB Reading International, Inc (Class B | €7,0214 | -5,64% | €169,04M | €39,34 | |
NHS Neuberger High Yield Strategies Fund Inc. | €5,4300 | +0,00% | €168,94M | €113,04K | |
RBKB Rhinebeck Bancorp, Inc. Common Stock | €15,0659 | +0,06% | €168,79M | €14,37K | |
EQ Equillium, Inc. Common Stock | €2,4396 | -4,12% | €168,62M | €758,17K | |
CBFV CB Financial Services, Inc. (PA) | €33,5944 | +0,73% | €168,28M | €1,70K | |
| €2,2210 | -1,17% | €167,89M | €168,96K | |
LFAC Leapfrog Acquisition Corporation Class A Ordinary Shares | €8,6828 | -0,70% | €167,42M | €7,869 | |
NRO Neuberger Real Estate Securities Income Fund Inc. | €2,7019 | +0,00% | €167,31M | €591,71K | |
FOCL EDAP TMS S.A. American Depositary Shares | €4,6168 | +1,93% | €167,14M | €50,56K | |
ORMP Oramed Pharmaceuticals Inc. | €4,0004 | -0,54% | €167,11M | €228,43K | |
HUMA Humacyte, Inc. Common Stock | €0,67390 | +8,55% | €167,06M | €8,16M | |
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP. | €4,1884 | -2,64% | €166,84M | €390,42K | |
